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• The vascular wall has the capacity to undergo remodel- 
ing in response to long-term changes or injuries. This is a pro- 
cess of structural rearrangement that involves cell growth, cell 
death, cell migration, cell modulation and secretion/degrada- 
tion of extracellular matrix molecules (1). Vascular remodel- 
ing is an adaptive phenomenon, e.g. Glagov's compensatory en- 
largement in atherosclerosis (2), but it may grow into vascular 
diseases (1), such as hypertension (3), atherosclerosis (4,5), and 
coronary restenosis after angioplasty (2,6, 7). Nowadays para- 
digms defining the cell biology of vascular diseases are the 
following: (/') the hypertensive vessel is characterized by hy- 
perinnervation-associated medial thickening due to smooth 
muscle cell (SMC) hypertrophy/hyperplasia and increased ex- 
tracellular matrix content, (;'/') the atherosclerotic plaque is 
characterized by SMC/immune cells/increased extracellular 
matrix-containing intimal thickening, and (Hi) the restenotic 
coronary artery is characterized by SMC/immune cells-contain- 
ing neointimal thickening. The spontaneously hypertensive rats 
(SHR), the stroke-prone SHR (SHRSP), the genetically hyper- 
tensive (GH) rats, and other genetically hypertensive strains are 
widely used as a model of human essential hypertension. In this 
volume of Biomedical Reviews, Bell (8) updates the knowledge 
about vascular wall neurotrophobiology in relation to the patho- 
genesis of hypertension in SHR and GH rats. Also, Kondo et al 
(9) systematize the perivascular nerve-related SMC structural 
changes in the development of hypertension in SHR and 
SHRSP. The data presented in these reviews are evaluated 
mainly in terms of Levi-Montalcini's neurotrophic theory (10). 
See Reviews on pages 43 and 57 
In this context, the role of immune cells in neural-effector in- 
teractions should also be considered (see 8 andRefs 23,113-120 
therein). The neurobiology of immune cells is one of the ex- 
panding fields of neuroscience research, largely due to the in- 
volvement of cytokines and neurotrophins in neuroimmune 
interactions (11). Besides the neurotrophic support of specific 
populations of neurons, there is an increasing evidence that 
nerve growth factor (NGF) is "not just for neurons" (12), e.g. 
it also exerts immunotrophic effects on mast cells and lympho- 
cytes (13, 14). Conversely, stem cell factor (mast cell growth 
factor, c-kit ligand) and leukemia inhibitory factor are not just 
for immune cells, they also possess neurotrophic effects (11, 
15). This Editorial will attempt to apply lessons learned from 
the study of vascular diseases and ageing to the trophobiology 
of vascular remodeling in hypertension. 
• Lesson from atherosclerosis: do not Ignore adventitial 
immune cells and perivascular nerves 
In 1962 Schwartz (cited by 16) wrote with respect to the pres- 
ence of adventitial mononuclear cell infiltration of atheroscle- 
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rotic vessels: "It is perhaps surprising that such prominent 
cellular accumulation should have received so little attention... 
Nevertheless, since cellular infiltration of the adventitia shows 
such a constant relationship to the presence and degree of 
plaque formation, it should not be disregarded". This and other 
related works have been largely ignored (16 and Refs therein), 
and the atherosclerosis research for a long time has been fo- 
cused on the intimal changes, appreciating extravasation of 
immune cells through the arterial lumen, SMC proliferation 
and hypersecretion of extracellular matrix molecules by SMC 
(reviewed in 4, 5,17, in which the word "adventitia" is concep- 
tually absent). However, the observation that adventitial injury 
alone can lead to intimal thickening is an evidence for the 
dynamic interaction between the adventitia and intima. Ex- 
amples of such adventitial injuries include (/) chronic applica- 
tion of lipopolysaccharide (18) and interleukin-lp (19) to the 
vascular adventitia, (/'/') placement of a cuff around the adven- 
titial surface (20), and (Hi) removal of the adventitia (21-23). 
Together these studies suggest a potential role of adventitial im- 
mune cells and perivascular nerves in atherosclerosis (Fig. 1). 
Studies aiming at further evaluation of a neural-immune rela- 
tionship in atherosclerotic adventitia (29-32) are needed. 
• Lesson from coronary restenosis: do not ignore adven- 
titial fibroblasts 
In 1983 at the seminar organized by Dr George Pappas (Depart- 
ment of Anatomy, Medical School, University of Illinois, Chi- 
cago, IL), one of us (GNC) delivered a lecture entitled "The fine 
structure of secretory-state SMC and their possible role in oc- 
clusive arterial diseases". During the discussion, the question 
whether some adventitial fibroblasts may migrate to the intima 
was raised. The answer of the author was "I do not know. It 
seems impossible." However, what seemed "impossible" in 
1983 was proven possible in 1996 when Shi et al (6) and 
Wilcox and Scott (16) summarized their results indicating that 
the adventitial fibroblasts proliferate and modulate their phe- 
notype to myofibroblasts migrating to the luminal surface of the 
balloon-injured coronary arteries, thus contributing to the 
neointimat formation. Also, it was recently suggested that 
neoadventitial formation, consisted of fibrotic tissue and mono- 
nuclears, could play an important role in coronary restenosis by 
circumferential neoadventitial, scar-like contraction, which 
may cause luminal narrowing (7). Collagen type I involvement 
in cerebral vasospasm (33) may also be at work for adventitial 
myofibroblast contraction in restenosis. Altogether these data 
  
 
Figure 1. A scheme summarizing data about the role of perivascular nerves in the pathogenesis of hypertension and 
atherosclerosis, including denervation-associated transplant coronary arteriosclerosis (3, 8, 9, 21-24). Question marks 
are depicted because of missing data about the role of perivascular nerves for vascular immune cell biology. In other 
tissues, the denervation results in monocyte invasion into superior cervical ganglion (25), mast cell proliferation in spleen 
(26), lung (26) and gut (27), and mast cell activation in dura mater (28). SMC - smooth muscle cell. 
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suggest an important role of adventitial fibroblasts in, and bring 
into question the sole contribution of SMC to neoinlimal thick- 
ening in coronary restenosis. Moreover, they may bring us back 
in 1886 to Langhans' description of stellate-shaped cells in ath- 
erosclerotic plaques (see 34), thus prompting us to reappreciate 
Virchow's original opinion about the fibroblast nature of these 
cells. It should also be noted that a large proportion of the in- 
timal foam cells may be derived from foam cells of the media 
and adventitia rather than from the lumen, after balloon angio- 
plasty of cholesterol-fed rabbits (35).  
• Lesson from ageing: adventitial immune cells and 
fibroblasts may also provide a neurotrophic support to peri- 
vascular nerves 
Ultrastructurally, perivascular nerve-immune cell (36, 37) and 
adventitial fibroblast-mast cell (38, 39) links are found in ce- 
rebral arteries. Furthermore, there is a correlation between (/) 
degeneration of SMC, (»') decreased number of adventitial mast 
cells (see also 40 for human coronary arteries), and (///) atro- 
phy of adventitial fibroblasts (37-39), suggesting that a reduc- 
tion in the availability of neurotrophins derived from SMC (8, 
14), mast cells and/or fibroblasts probably contributes to the de- 
creased density of perivascular nerves during ageing of cerebral 
arteries (38, 39). These data bring into question the sole con- 
tribution of effector SMC to neurotrophic support to perivascu- 
lar nerves as currently believed. 
• Implication of the lessons: appreciate the adventitia in 
hypertension  
In hypertension research, in contrast to atherosclerosis and 
restenosis, a considerable attention has been paid to the perivas- 
cular nerves and their trophic interactions with the medial SMC 
(3, 8, 9), leaving adventitial immunocytes and fibroblasts ig- 
nored. Hence, the morphometry of hypertensive vascular wall 
traditionally includes measurements of (lie cross-sectional area 
of intima and media and calculation of media/lumen ratio, the 
adventitial area being commonly neglected, with an exception 
of Lee et al (42, 43). These authors showed that neonatal 
sympathectomy alone and its combination with bilateral adre- 
nal demedullation cause adventitial thickening in mesenteric 
arteries both in SHR and Wistar-Kyoto (WKY) rats. Also, Lee 
et al (43) found a significant increase in the adventitial thick- 
ness in SHR compared to that in WKY rats. The importance of 
the adventitial thickening in SHR arteries and in arteries from 
sympathectomized animals is unclear. It is known that sympa- 
thetic hyperactivity (3, 8, 9) as well as sympathectomy (24) 
results in collagen overproduction (see Fig. 1). Recent findings 
show that angiotensin II-induced medial hypertrophy occurs in 
densely but not sparsely innervated rat arteries (44). These au- 
thors suggest a perivascular nerve-mediated hypertrophic effect 
of angiotensin II. Such a mechanism may also operate in 
antinecrotic (9) and/or antiapoptotic (45) action of angiotensin 
II in vascular SMC. Note that cardiac mast cell-derived chymase 
possesses angiotensin I-converting enzyme activity and thus 
contributes to cardiovascular fibrosis (46). Hence, immune cells 
in cooperation with medial SMC and with adventitial fibro- 
blasts may be involved in the fibrogenesis of hypertension (see 
Solomon and Levi-Schaffer [47] in this volume of Biomedical 
Reviews for mast cell-fibroblast interactions in fibrotic diseases, 
and 48, 49 for immune cells and hypertensive heart fibrosis). 
Moreover, evidence is accumulating that bidirectional trophic 
interactions exist between perivascular nerves and endothelium 
(50, see also 18-24 mentioned in Lesson from atherosclerosis). 
"It is thus intriguing that loss of substance P (SP) in nerves at 
the adventitia results in increase in SP at the intima" in the rat 
pulmonary artery (51). However, results from the same research 
group "indicate that endothelial substance P is unrelated to the 
substance P content of sensory nerves since there was no differ- 
ence in endothelial substance P after capsaicin treatment" in rat 
mesenteric arteries (52). This could represent a form of 
intervascular heterogeneity (3). Furthermore, endothelial injury 
enhances the density of SP-positive perivascular nerves (50). 
The mechanism by which such an adventitia-endothelium 
cross-talk operates remains unknown. Possibly, the easily dif- 
fusible nitric oxide (53) and carbon monoxide (54), the nexuses 
between medial SMC, and the adventitial immune cell-derived 
cytokines carried into the vessel wall by the vasa vasorum could 
mediate the adventitia-endothelium bidirectional interaction. 
Until such mediators are not discovered, we suggest they be 
named burnstockines, to appreciate the contribution of 
Burnstock and coworkers (50, 51). 
•        Conclusion 
The presented data bring into question the sole contribution of 
vascular SMC to neurotrophic support and, eventually, to 
medial hypertrophy in hypertensive blood vessels. They raise 
the significant possibility that a concerted action of different 
neurotrophins and cytokines derived from multiple cellular 
sources, i.e. medial SMC, adventitial immune cells and adven- 
titial fibroblasts, is involved in the neurotrophobiology and 
fibrogenicity of hypertension. This is a substantial part of the 
hypothesis of neural-immune-effector trophic interactions (38, 
39), which application to hypertension research may provide 
new insights into the pathogenesis and therapy of essential hy- 
pertension (Fig.2). In effect, we should recognize that we have 
paid less attention to the neurotrophic and fibrogenic potentials 
of the adventitia in vascular remodeling in hypertension. Per- 
haps it is time to change that. : 
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Figure 2. Suggested role of adventitia-based trophic interactions in vascular remodeling in hypertension. Note that three 
cell types may provide rnultifactorial neurotrophic support (arrows in bold). 
Abbreviations and the respective references: IL-1 - interleukin-1 (19, 55), TNF-a-tumor necrosis factor-a (11, 47, 55),NGF- 
nerve growth factor (11-14), NO - nitric oxide (50), E - endothelins (50), ATP - adenosine S'-triphosphate (56), A - adenos- 
ine (56), CT-1 - cardiotrophin-1 (57), Angll- angiotensin 11 (3, 44, 46), NT - neurotransrnitters (3, 8, 9, 11), Bk - burnstockines 
(50, 51), LIF- leukemia inhibitory factor (11), SCF-stem cell factor (mast cell growth factor) (15), H- histamine (47), FGF 
-fibroblast growth factor (47). Additional mediator molecules may also be involved but are not shown. 
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